About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
ATHX - Athersys| Previous Close | $3.12 | Open | |
| Volume | Market Cap | 269.6M | |
| Yield | Last Dividend |
| Athersys Announces Upcoming Presentation... | 05/18/20 |
| CLEVELAND--(BUSINESS WIRE)---- $ATHX #ARDS--Athersys taking a leading role at the International Society of Cell ad Gene Therapy Conference and will di... | |
| Athersys Reports First Quarter 2020 Resu... | 05/07/20 |
| CLEVELAND--(BUSINESS WIRE)---- $ATHX #ARDS--Athersys Q1 Earnings reflects multiple achievements for the Company, including obtaining FDA authorization... | |
| Athersys Announces Commencement of Patie... | 05/05/20 |
| CLEVELAND--(BUSINESS WIRE)---- $ATHX #ARDS--The first patients have been enrolled in the Athersys COVID-19 induced ARDS clinical program using MultiSt... | |
| Athersys and University Hospitals Clevel... | 05/01/20 |
| CLEVELAND--(BUSINESS WIRE)---- $ATHX #ARDS--The first clinical site is now open for the MACOVIA study, a pivotal Phase 2/3 study evaluating MultiStem?... | |
| Athersys to Present at the Bank of Ameri... | 04/29/20 |
| CLEVELAND--(BUSINESS WIRE)--Athersys presentation scheduled for May 14, 2020 at 8:20 AM EDT. A live webcast will be available at https://tinyurl.com/y... | |
| Trump Demands Harvard Return Stimulus Mo... | 04/21/20 |
| Trump Demands Harvard Return Stimulus Money; Harvard Responds It Has No Idea What Trump Is Talking About The resentment against publicly-traded compan... | |
| Athersys Announces Closing of Public Off... | 04/20/20 |
| CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX) (Athersys) today announced the closing of its previously announced underwritten public offer... | |
| Athersys Announces Pricing of Public Off... | 04/15/20 |
| CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX) (Athersys) today announced the pricing of its previously announced underwritten public offer... | |
| Biocept To Begin COVID-19 Testing; BioCr... | 04/13/20 |
| As the COVID-19 pandemic continues to ravage the globe, having claimed over 115,000 lives, health care companies have are pursuing diagnostics tests, ... | |
| Athersys's stock shoots up after FDA OKs... | 04/13/20 |
| Shares of Athersys Inc. undefined shot up 26.5% in premarket trading Monday, after the company said it has received Food and Drug Administration??? | |
| FDA Authorizes Athersys to Initiate a Pi... | 04/13/20 |
| CLEVELAND--(BUSINESS WIRE)-- #ARDS--Company plans to initiate a Phase 2/3 pivotal study in patients with COVID-19 induced ARDS this quarter | |
| Cleveland biotech company making headway... | 04/01/20 |
| Athersys, a Cleveland biotech company, says it is making headway on a possible stem cell treatment for the COVID-19 virus. | |
| The Daily Biotech Pulse: InflaRx Begins ... | 04/01/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 31) At... | |
| Athersys Announces Financial Results for... | 03/16/20 |
| CLEVELAND--(BUSINESS WIRE)-- #ARDS--Clinical trial results in ARDS supported designation by BARDA as a "Highly Relevant" program for COVID-19 and othe... | |
| Athersys to Host Year-End 2019 Financial... | 02/10/20 |
| CLEVELAND--(BUSINESS WIRE)---- $ATHX--Athersys will host year-end 2019 financial results call on March 16, 2020. | |
| Athersys Announces Inducement Grant Unde... | 02/03/20 |
| CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (???Athersys??? or the ???Company???) (NASDAQ: ATHX) announced today that, as previously disclosed in its F... | |
| The Daily Biotech Pulse: Positive Adcom ... | 12/18/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 17) ... | |
| Healios Receives Notification of Orphan ... | 11/14/19 |
| Athersys, Inc. (ATHX) announced today that its collaborator in Japan, HEALIOS K.K. (???Healios???) received notification this week from the Pharmaceut... | |
| Were Hedge Funds Right About Souring On ... | 11/11/19 |
| Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through October 17th. Among them, Facebook and... | |
| Athersys: Potential Upside | 09/23/19 |
| I will give a quick overview of Athersys and their MultiStem product.What is ARDS and Ischemic Stroke, how will MultiStem treat those conditions, and ... | |
| Athersys, Inc. (NASDAQ:ATHX): Is It Grow... | 09/19/19 |
| As the US$224m market cap Athersys, Inc. (NASDAQ:ATHX) released another year of negative earnings, investors may be on??? | |
| Do Institutions Own Shares In Athersys, ... | 07/31/19 |
| The big shareholder groups in Athersys, Inc. (NASDAQ:ATHX) have power over the company. Large companies usually have??? | |
| Pluristem Therapeutics - The Hidden Nich... | 05/15/19 |
| No summary available. | |
| Here's Why Athersys Rose as Much as 15.2... | 05/14/19 |
| The FDA has given the company's lead drug platform a potential leg up in development. | |
| Athersys up 11% premarket on accelerated... | 05/14/19 |
| No summary available. | |
| Athersys: Stem Cell Therapy For Ischemic... | 05/13/19 |
| ATHX is developing a stem cell therapy that enlarges the window of treatment for ischemic strokes. The treatment does not compete with existing therap... | |
| Athersys (ATHX) Q1 2019 Earnings Call Tr... | 05/09/19 |
| ATHX earnings call for the period ending March 31, 2019. | |
| Athersys, Inc. (ATHX) Q1 2019 Results - ... | 05/08/19 |
| No summary available. | |
| Athersys misses by $0.01, misses on reve... | 05/08/19 |
| No summary available. | |
| Here's Why Athersys Is Soaring Today | 04/23/19 |
| The stem cell pioneer announced an update with its most important collaborator. | |
| Buy rating | 05/08/20 |
| Needham maintains Buy rating and lowers Price Target from $6.00 to $5.00 | |
| Date | 2020-05-07 (AMC) | Est. (EPS/Rev.) | ($0.08)/ 120K |
| Actual (EPS/Rev.) | $-0.10/ | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Mojo Day Trading | ProTrader Mike | 41.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
